193 related articles for article (PubMed ID: 21986028)
1. Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus.
Zhang L; Collins PL; Lamb RA; Pickles RJ
Virology; 2011 Dec; 421(1):67-77. PubMed ID: 21986028
[TBL] [Abstract][Full Text] [Related]
2. Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro.
Krilov LR; Hendry RM; Godfrey E; McIntosh K
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1749-53. PubMed ID: 3035067
[TBL] [Abstract][Full Text] [Related]
3. Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity.
Tang RS; Schickli JH; MacPhail M; Fernandes F; Bicha L; Spaete J; Fouchier RA; Osterhaus AD; Spaete R; Haller AA
J Virol; 2003 Oct; 77(20):10819-28. PubMed ID: 14512532
[TBL] [Abstract][Full Text] [Related]
4. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.
Guo-Parke H; Canning P; Douglas I; Villenave R; Heaney LG; Coyle PV; Lyons JD; Shields MD; Power UF
Am J Respir Crit Care Med; 2013 Oct; 188(7):842-51. PubMed ID: 23952745
[TBL] [Abstract][Full Text] [Related]
5. Human IFIT1 Inhibits mRNA Translation of Rubulaviruses but Not Other Members of the Paramyxoviridae Family.
Young DF; Andrejeva J; Li X; Inesta-Vaquera F; Dong C; Cowling VH; Goodbourn S; Randall RE
J Virol; 2016 Oct; 90(20):9446-56. PubMed ID: 27512068
[TBL] [Abstract][Full Text] [Related]
6. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders.
Lehners N; Tabatabai J; Prifert C; Wedde M; Puthenparambil J; Weissbrich B; Biere B; Schweiger B; Egerer G; Schnitzler P
PLoS One; 2016; 11(2):e0148258. PubMed ID: 26866481
[TBL] [Abstract][Full Text] [Related]
8. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
Nelson CL; Tang RS; Stillman EA
Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
[TBL] [Abstract][Full Text] [Related]
9. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
Tang RS; MacPhail M; Schickli JH; Kaur J; Robinson CL; Lawlor HA; Guzzetta JM; Spaete RR; Haller AA
J Virol; 2004 Oct; 78(20):11198-207. PubMed ID: 15452239
[TBL] [Abstract][Full Text] [Related]
10. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.
Zhang L; Bukreyev A; Thompson CI; Watson B; Peeples ME; Collins PL; Pickles RJ
J Virol; 2005 Jan; 79(2):1113-24. PubMed ID: 15613339
[TBL] [Abstract][Full Text] [Related]
11. Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs.
Garg R; Latimer L; Gomis S; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
Antiviral Res; 2019 Feb; 162():54-60. PubMed ID: 30550799
[TBL] [Abstract][Full Text] [Related]
12. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.
Avadhanula V; Rodriguez CA; Devincenzo JP; Wang Y; Webby RJ; Ulett GC; Adderson EE
J Virol; 2006 Feb; 80(4):1629-36. PubMed ID: 16439519
[TBL] [Abstract][Full Text] [Related]
13. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after
Phan SI; Adam CM; Chen Z; Citron M; Liang X; Espeseth AS; Wang D; He B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747497
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
[TBL] [Abstract][Full Text] [Related]
15. Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine.
Yang CF; Wang CK; Malkin E; Schickli JH; Shambaugh C; Zuo F; Galinski MS; Dubovsky F; ; Tang RS
Vaccine; 2013 Jun; 31(26):2822-7. PubMed ID: 23602668
[TBL] [Abstract][Full Text] [Related]
16. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
Kinder JT; Moncman CL; Barrett C; Jin H; Kallewaard N; Dutch RE
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759319
[TBL] [Abstract][Full Text] [Related]
18. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
Antiviral Res; 2018 Oct; 158():78-87. PubMed ID: 30071204
[TBL] [Abstract][Full Text] [Related]
19. Improvement of respiratory syncytial virus replication in actively growing HEp-2 cells.
Pons MW; Lambert AL; Lambert DM; Rochovansky OM
J Virol Methods; 1983 Oct; 7(4):217-21. PubMed ID: 6317708
[TBL] [Abstract][Full Text] [Related]
20. Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.
Tao T; Durbin AP; Whitehead SS; Davoodi F; Collins PL; Murphy BR
J Virol; 1998 Apr; 72(4):2955-61. PubMed ID: 9525616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
